PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower MillerKnoll MLKN Stock Is It Losing Strength MillerKnoll posts 63 EPS miss vs analyst targets Auna AUNA Stock Is It a Compelling Buy Q4 2025 Profit Exceeds Views